ClinicalTrials.Veeva

Menu

Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients

K

Kuopio University Hospital

Status

Completed

Conditions

Sepsis

Treatments

Other: Severe sepsis vs. non-severe sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT00781040
KUH5101409

Details and patient eligibility

About

The aim of this study is to find out whether inflammation markers including cardiac markers have predictive value in evaluation of pathogenesis of sepsis in neutropenic haematological patients.

Full description

Adult AML and ASCT patients with neutropenic fever. Observation of possible progress to severe sepsis or septic shock. Blood sample collection on days 0-3 (from the beginning of neutropenic fever).

Enrollment

273 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis: acute myeloid leukaemia
  • age under 70 years
  • neutropenic fever

Exclusion criteria

  • age above 70 years
  • no neutropenic fever

Trial design

273 participants in 1 patient group

Neutropenic patients
Description:
Adult AML and ASCT patients with neutropenic fever.
Treatment:
Other: Severe sepsis vs. non-severe sepsis

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems